We are live on ! Find out more
ELI

ELITE PHARMACEUTICAL
ELI

Delisted

ELI was delisted on the 20th of May, 2009.

Back to rankings

1 hedge funds and large institutions have $2.25K invested in ELITE PHARMACEUTICAL in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$2.25K

Top Sellers

No sellers this quarter

ELI Hedge Fund Activity: Q1 2025 in Review

1 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in ELITE PHARMACEUTICAL (ELI) for Q1 2025, worth a combined $2.25K.

Buyers outnumbered sellers: 1 fund opened new ELI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Ancora Advisors, opening a new position worth an estimated $2.25K.

  • 1 institutional investor held ELITE PHARMACEUTICAL (ELI) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $2.25K of ELITE PHARMACEUTICAL stock for Q1 2025.
  • 1 fund opened new ELITE PHARMACEUTICAL positions in Q1 2025 and 0 closed out, a net change of +1 holder.
  • The largest ELITE PHARMACEUTICAL buyer in Q1 2025 was Ancora Advisors, an estimated $2.25K added.

Based on aggregated 13F filings for Q1 2025.